APA-viite

Itzler, R., Koch, G., Matson, D. O., Gothefors, L., Van Damme, P., DiNubile, M. J., & Heaton, P. M. (2010). Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5). BioMed Central.

Chicago-tyylinen lähdeviittaus

Itzler, Robbin, Gary Koch, David O. Matson, Leif Gothefors, Pierre Van Damme, Mark J. DiNubile, ja Penny M. Heaton. Robustness of the Healthcare Utilization Results From the Rotavirus Efficacy and Safety Trial (REST) Evaluating the Human-bovine (WC3) Reassortant Pentavalent Rotavirus Vaccine (RV5). BioMed Central, 2010.

MLA-viite

Itzler, Robbin, et al. Robustness of the Healthcare Utilization Results From the Rotavirus Efficacy and Safety Trial (REST) Evaluating the Human-bovine (WC3) Reassortant Pentavalent Rotavirus Vaccine (RV5). BioMed Central, 2010.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.